Cynapsus Therapeutics
Cynapsus Therapeutics is a pharmaceutical subsidiary of Sunovion developing a non-injectable rescue therapy for Parkinson’s disease symptoms. The company was founded in 2004 and is headquartered in Toronto, Ontario, Canada.
Key facts
| Company Operating Status | Active |
|---|---|
| Full Address | 828 Richmond Street West Toronto, Ontario M6J 1C9 Canada |
| Stock Symbol | CTH |
| Wellfound ID | cynapsus-therapeutics |
| Wikidata ID | Q5199886 |